ALBERT DAVID
Back to Balance Sheet
|
ALBERT DAVID Last 5 Year Total Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹637 Cr | ₹625 Cr | ₹604 Cr | ₹512 Cr | ₹475 Cr |
What is the latest Total Liabilities ratio of ALBERT DAVID ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹637 Cr |
| Mar2025 | ₹625 Cr |
| Mar2024 | ₹604 Cr |
| Mar2023 | ₹512 Cr |
| Mar2022 | ₹475 Cr |
How is Total Liabilities of ALBERT DAVID Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹637 Cr | 1.93 | |
| Mar2025 | ₹625 Cr | 3.34 | |
| Mar2024 | ₹604 Cr | 17.98 | |
| Mar2023 | ₹512 Cr | 7.82 | |
| Mar2022 | ₹475 Cr | - | |
Compare Total Liabilities of peers of ALBERT DAVID
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALBERT DAVID | ₹390.9 Cr | -0.6% | -3.8% | -23.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,842.0 Cr | -0.4% | 4.3% | 13.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,860.0 Cr | 0.9% | 8.9% | 8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹192,687.0 Cr | 0.7% | 13% | 46.5% | Stock Analytics | |
| CIPLA | ₹112,593.0 Cr | -1% | -0% | -3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,364.9 Cr | -3.3% | -8.4% | -4.3% | Stock Analytics | |
ALBERT DAVID Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALBERT DAVID | -0.6% |
-3.8% |
-23.1% |
| SENSEX | -1% |
-0.9% |
-7.5% |
You may also like the below Video Courses